Clinical trial

Diabetes Risk Communication Tool Evaluation

NCT05427890

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2022-06-20

PhaseNA

Study timeline

Study start (actual)2022-06-20Date precision: day

Registry last updated2023-09-21

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Type 2 Diabetesunresolved

Interventions

T2D Risk Communication Tool: Relative RiskBEHAVIORAL

T2D Risk Communication Tool: Metabolic AgeBEHAVIORAL

T2D Risk Communication Tool: Traffic LightBEHAVIORAL

Sponsors & collaborators

National University of Singaporelead sponsor

National Medical Research Council (NMRC), Singaporecollaborator

Mapped research locations

SingaporeSingapore1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT05427890 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.